218 related articles for article (PubMed ID: 26346543)
1. Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.
Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini RM; de Nully Brown P; Glimelius B; Adami HO; Melbye M; Glimelius I; Hjalgrim H
Am J Epidemiol; 2015 Oct; 182(7):624-32. PubMed ID: 26346543
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.
Landgren O; Engels EA; Pfeiffer RM; Gridley G; Mellemkjaer L; Olsen JH; Kerstann KF; Wheeler W; Hemminki K; Linet MS; Goldin LR
J Natl Cancer Inst; 2006 Sep; 98(18):1321-30. PubMed ID: 16985251
[TBL] [Abstract][Full Text] [Related]
3. Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.
Linabery AM; Erhardt EB; Fonstad RK; Ambinder RF; Bunin GR; Ross JA; Spector LG; Grufferman S
Int J Cancer; 2014 Sep; 135(6):1454-69. PubMed ID: 24523151
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.
Hjalgrim H; Ekström-Smedby K; Rostgaard K; Amini RM; Molin D; Hamilton-Dutoit S; Schöllkopf C; Chang ET; Ralfkiaer E; Adami HO; Glimelius B; Melbye M
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1561-6. PubMed ID: 17684129
[TBL] [Abstract][Full Text] [Related]
7. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.
Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundström C; Adami HO; Glimelius B; Melbye M
Cancer Res; 2007 Mar; 67(5):2382-8. PubMed ID: 17332371
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).
Kamper-Jørgensen M; Rostgaard K; Glaser SL; Zahm SH; Cozen W; Smedby KE; Sanjosé S; Chang ET; Zheng T; La Vecchia C; Serraino D; Monnereau A; Kane EV; Miligi L; Vineis P; Spinelli JJ; McLaughlin JR; Pahwa P; Dosman JA; Vornanen M; Foretova L; Maynadie M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Hjalgrim H
Ann Oncol; 2013 Sep; 24(9):2245-55. PubMed ID: 23788758
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and Hodgkin lymphoma in Jordan.
Sughayer MA; Haddad HA; Al-Yousef RM; El-Khateeb M; Abu-Rass H
Hematol Oncol Stem Cell Ther; 2014 Jun; 7(2):85-9. PubMed ID: 24472289
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Jul; 25(7):1397-1404. PubMed ID: 24718892
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated Hodgkin's lymphoma.
Gandhi MK; Tellam JT; Khanna R
Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
[TBL] [Abstract][Full Text] [Related]
12. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
14. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
17. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women.
Glaser SL; Keegan TH; Clarke CA; Trinh M; Dorfman RF; Mann RB; DiGiuseppe JA; Ambinder RF
Int J Cancer; 2005 Jul; 115(4):599-605. PubMed ID: 15700307
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.
Morales O; Mrizak D; François V; Mustapha R; Miroux C; Depil S; Decouvelaere AV; Lionne-Huyghe P; Auriault C; de Launoit Y; Pancré V; Delhem N
Br J Haematol; 2014 Sep; 166(6):875-90. PubMed ID: 25041527
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome.
Chabay PA; Barros MH; Hassan R; De Matteo E; Rey G; Carrico MK; Renault IZ; Preciado MV
J Pediatr Hematol Oncol; 2008 Apr; 30(4):285-91. PubMed ID: 18391697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
